Anteris Technologies Global (AVR) stock, explained like you're 5

Is Anteris Technologies Global a small, medium or large cap company?

No. Anteris Technologies Global is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 660 million dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Anteris Technologies Global makes money

• Selling medicines, medical devices or healthcare services.
• Insurance premiums or hospital and clinic fees.
• Research and licensing deals.

What moves AVR stock

• Results from clinical trials and approvals from regulators.
• Drug prices, insurance rules and government policy.
• Patents running out and new competing treatments.

In the news lately

• The Technical Signals Behind (AVR) That Institutions Follow (Stock Traders Daily)
• Funds buy 272,695 Anteris Technologies (AVR) shares, with a resulting position of 6,358,271. (Stock Titan)
• Insider Sale: 10% owner at $AVR Sells 174,721 Shares | AVR Stock News (Quiver Quantitative)
• Anteris Technologies Stock Looks Bullish If DurAVR's PARADIGM Delivers (NASDAQ:AVR) (Seeking Alpha)
• AVR Stock Pops Pre Market: Medtronic Backs $200M Capital Raise To Fund Key Trial (Stocktwits)

Key terms to know before you follow AVR

• Market cap
• P/E ratio
• EPS (earnings per share)
• Earnings report
• Volatility